Role of CD8 + Lymphocytes in Control of Simian Immunodeficiency Virus Infection and Resistance to Rechallenge after Transient Early Antiretroviral Treatment

Author:

Lifson Jeffrey D.1,Rossio Jeffrey L.1,Piatak Michael1,Parks Thomas1,Li Li1,Kiser Rebecca2,Coalter Vicky2,Fisher Brad3,Flynn Bernard M.3,Czajak Susan4,Hirsch Vanessa M.5,Reimann Keith A.6,Schmitz Joern E.6,Ghrayeb John7,Bischofberger Norbert8,Nowak Martin A.9,Desrosiers Ronald C.4,Wodarz Dominik9

Affiliation:

1. Retroviral Pathogenesis Laboratory1and

2. Vaccine Support Laboratory,2 AIDS Vaccine Program, SAIC Frederick, National Cancer Institute at Frederick, Frederick, Maryland 21702;

3. Animal Sciences Branch, National Cancer Institute, Bethesda, Maryland 208923;

4. New England Regional Primate Research Center, Harvard Medical School, Southborough, Massachusetts 017724;

5. Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 208525;

6. Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Boston, Massachusetts 022156;

7. Centocor, Inc., Malvern, Pennsylvania 193557;

8. Gilead Sciences, Inc., Foster City, California 944048; and

9. Program in Theoretical Biology, Institute of Advanced Study, Princeton, New Jersey 085409

Abstract

ABSTRACT Transient antiretroviral treatment with tenofovir, ( R )-9-(2-phosphonylmethoxypropyl)adenine, begun shortly after inoculation of rhesus macaques with the highly pathogenic simian immunodeficiency virus (SIV) isolate SIVsmE660, facilitated the development of SIV-specific lymphoproliferative responses and sustained effective control of the infection following drug discontinuation. Animals that controlled plasma viremia following transient postinoculation treatment showed substantial resistance to subsequent intravenous rechallenge with homologous (SIVsmE660) and highly heterologous (SIVmac239) SIV isolates, up to more than 1 year later, despite the absence of measurable neutralizing antibody. In some instances, resistance to rechallenge was observed despite the absence of detectable SIV-specific binding antibody and in the face of SIV lymphoproliferative responses that were low or undetectable at the time of challenge. In vivo monoclonal antibody depletion experiments demonstrated a critical role for CD8 + lymphocytes in the control of viral replication; plasma viremia rose by as much as five log units after depletion of CD8 + cells and returned to predepletion levels (as low as <100 copy Eq/ml) as circulating CD8 + cells were restored. The extent of host control of replication of highly pathogenic SIV strains and the level of resistance to heterologous rechallenge achieved following transient postinoculation treatment compared favorably to the results seen after SIVsmE660 and SIVmac239 challenge with many vaccine strategies. This impressive control of viral replication was observed despite comparatively modest measured immune responses, less than those often achieved with vaccination regimens. The results help establish the underlying feasibility of efforts to develop vaccines for the prevention of AIDS, although the exact nature of the protective host responses involved remains to be elucidated.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference46 articles.

1. The role of CD4+ T helper cells in the cytotoxic T lymphocyte response to HIV-1;Altfeld M.;Curr. Opin. Immunol.,2000

2. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection;Altfeld M.;J. Exp. Med.,2001

3. Simian immunodeficiency virus: production, inactivation, and characterization;Arthur L. O.;AIDS Res. Hum. Retroviruses,1998

4. CD56 identifies monocytes and not natural killer cells in rhesus macaques;Carter D. L.;Cytometry,1999

5. HIV 1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes;Collins K. L.;Nature,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3